0001884863-25-000004.txt : 20251218 0001884863-25-000004.hdr.sgml : 20251218 20251217201945 ACCESSION NUMBER: 0001884863-25-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251218 DATE AS OF CHANGE: 20251217 EFFECTIVENESS DATE: 20251218 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ceretype Neuromedicine, Inc. CENTRAL INDEX KEY: 0001884863 ORGANIZATION NAME: EIN: 831967073 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-567252 FILM NUMBER: 251581029 BUSINESS ADDRESS: STREET 1: 1 BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 212-209-3050 MAIL ADDRESS: STREET 1: 1 BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0708 D LIVE 0001884863 Ceretype Neuromedicine, Inc. 1 Broadway, 14th Floor Cambridge MA MASSACHUSETTS 02142 917-796-7706 DELAWARE None None Corporation true Emily Stern 1 Broadway, 14th Floor Cambridge MA MASSACHUSETTS 02142 Executive Officer Director David Silbersweig 1 Broadway, 14th Floor Cambridge MA MASSACHUSETTS 02142 Director Richard Lipkin 1 Broadway, 14th Floor Cambridge MA MASSACHUSETTS 02142 Director Biotechnology Decline to Disclose 06b false 2024-08-06 true true false 0 400000 400000 0 false 3 0 0 0 false Ceretype Neuromedicine, Inc. /s/ Emily Stern Emily Stern Chief Executive Officer 2025-09-29